Company: WAL-PA
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057334
Chunk: 22

Company: WESTERN ALLIANCE BANCORPORATION
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 22
---
 any new investment, business initiatives, tax planning strategies, debt, equity capital, and/or derivative or hedging strategies prior to the introduction of the product;Review any relevant reports rendered by the Company’s internal audit and compliance departments, and external auditors, and work with the Audit Committee, as appropriate, to ensure that any necessary corrective actions are taken and achieved;Review any relevant reports received from bank regulators regarding the activities of the Finance and Investment Committee;Oversee the issuance of debt and equity offerings and stock repurchase plans; andReview any material required as part of bank run capital stress testing, including models, financial schedules and supporting artifacts and approve final stress testing results and any management recommended actions. |

Ms. Kuras served on the Finance and Investment Committee during 2024 and is independent. Dr. Sohn and Mr. Galant also served on the Finance and Investment Committee during 2024 and were independent.

| 26 | 2025 PROXY STATEMENT |

| CORPORATE GOVERNANCE |

| Risk Committee | Meetings during 2024: 8 |

|                  |     |           |     |                |     |           |     |           |     |           |     | ALLINDEPENDENT |
| Mr. Gould, Chair |     | Mr. Beach |     | Ms. Guggenheim |     | Ms. Kuras |     | Mr. Latta |     | Mr. Meola |     |                |

|                                   | Primary Responsibilities                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |     | ·   ·   ·       ·      ·    ·    · | Review and approve any other matters related to risk management or compliance as required by the Company’s regulators; Monitor management’s implementation of the Company’s Compliance Management System Framework;Review the amount, nature, characteristics, concentration, and quality of the Company's credit-related risks; significant exposures are monitored through reports presented to the Risk Committee and include reporting of significant exceptions to risk policies and trends in portfolio quality (credit and position risk) and market risk;Monitor management’s implementation of the Company’s Financial Crimes Compliance program, including reviewing related policies, risk assessment results and monitoring efforts (e.g., Bank Secrecy Act/Anti-Money Laundering/Office of Foreign Assets Control metrics);Monitor management’s implementation of Operations and Technology risk including, cyber security, information security, Business Continuity and Disaster Recovery programs;Review and approve annually the level and adequacy of the Company’s insurance program, policies and coverage limits, including an